# Sienna Biopharmaceuticals, Inc. (SNNAQ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SNNAQ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2019 | $ 0 | $ -36.94M | $ -50.38M | $ 0 | $ 23.10M |
| 2018 | $ 0 | $ -96.98M | $ -81.53M | $ 30.13M | $ 159.37M |
| 2017 | $ 0 | $ -68.09M | $ -55.71M | $ 0 | $ 85.90M |
| 2016 | $ 0 | $ -29.12M | $ -24.65M | $ 0 | $ 22.12M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.88 |
| Current Ratio | 15.27 |

## Other views

- [Metrics](https://sponda.capital/en/SNNAQ.md)
- [Charts](https://sponda.capital/en/SNNAQ/charts.md)
- [Compare](https://sponda.capital/en/SNNAQ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.